Following the launch of its Pipetgirl pink pipette controller in support of breast cancer research earlier this year, Integra has donated $10,000 to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute in Boston, US.
The Centre unites many of the world’s leading experts in breast and gynecologic cancers with the goal of giving woman the latest, most advanced care, including innovative therapies that are often available only through clinical trials.
It provides multi-dimensional services to strengthen mind, body, and soul and to help alleviate mental and emotional burdens.
Marc Hamel, director of US sales at Integra, said: “During our visit to Dana-Farber Cancer Institute, we learned so much about the incredible work being undertaken at this prestigious patient treatment facility specifically in the area of breast cancer.
“Empowered by the laboratory community’s enthusiastic response to our Pipetgirl pipette controller, I am delighted that we have reached our first milestone - a $10,000 contribution to Dana-Farber.”
Likewise, Courtney Hadden, associate director, corporate partnerships, Dana-Farber and the Jimmy Fund, said: “We are honoured to partner with Integra and truly grateful for their generous support of Dana-Farber’s Susan F. Smith Center for Women’s Cancers.
“Integra’s commitment is admirable and critical to furthering the important work in research and care for women’s cancers taking place at the Centre.”
Earlier this year, Integra decided to make Pipetgirl a symbol of its commitment to support breast cancer research, committing to donate 10€/$15 for every purchase of Pipetgirl to research institutes dedicated to finding a cure for breast cancer.
The Pipetgirl pipette controller combines precision, speed, ease of use, lightweight operating comfort, long battery life and reliability.
It is designed for use with all commercially available glass and plastic serological pipettes in the volume range 1 - 100 ml. Each model comes with a three-year extended warranty.
